表紙
市場調查報告書
商品編碼
1046434

血管閉合設備的全球市場 - 市場規模、佔有率、趨勢分析:各類型,各接取,各治療,各地區的預測,競爭策略,市場區隔預測 (到2030年)

Global Vascular Closure Device Market Size, Share & Trends Analysis Report By Type, By Access, By Procedure, Regional Outlook, Competitive Strategies and Segment Forecast - 2030

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 206 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球血管閉合設備的市場規模,從2021年的11億2,000萬美元,預計到2030年達到15億8,000萬美元,以7.4%的年複合成長率成長。心血管障礙全球負擔,在全球引起年度約1,700萬人的死亡。預計心血管障礙的患者數,隨著老年人口增加,今後數年持續增加。

本報告提供全球血管閉合設備市場相關調查分析,市場概要,促進因素、課題、機會,市場分析,主要企業等相關的系統性資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
  • COVID-19對血管閉合設備市場的影響
  • 市場趨勢

第5章 全球血管閉合設備市場:各類型 (2021年∼2030年)

  • 被動式合攏器
  • 活性合攏器
  • 外部止血設備

第6章 全球血管閉合設備市場:各接取 (2021年∼2030年)

  • 股骨
  • 橈骨

第7章 全球血管閉合設備市場:各治療 (2021年∼2030年)

  • 介入性心臟學
  • 介入性無線電生物學/血管手術

第8章 全球血管閉合設備市場:各地區 (2021年∼2030年)

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他的亞太地區
  • 其他地區
    • 南美
    • 中東、非洲

第9章 競爭情形

  • 簡介
  • 市場佔有率分析:各主要企業 (2021年)
  • 競爭模式

第10章 企業簡介

  • Abbott, Cardinal Health
  • Advanced Vascular Dynamics
  • Boston Scientific Corporation
  • Cardiva Medical, Inc.
  • Marine Polymer Technologies, Inc.
  • Medas USA
  • Medtronic
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems, Inc.
  • Morris Innovative, Inc.
  • Rex Medical
  • Scion BioMedical
  • Teleflex Incorporated
  • Terumo Corporation
  • Transluminal Technologies
  • Tricol Biomedical
  • TZ Medical
  • Vasorum Ltd.
  • Vivasure Medical Ltd.
  • Vygon Company

第11章 附錄

目錄
Product Code: MEDE2202

Global vascular closure device market is projected to worth USD 1.58 Bn by 2030.

According to SPER Market Research, the global vascular closure device market was valued at USD 1.12 Bn in 2021 and estimated to reach USD 1.58 Bn by 2030 with a CAGR of 7.4%. The global burden of cardiovascular disorders causes around 17 Mn deaths per year across the globe. The number of patients with cardiovascular disorder will continue to grow as the geriatric population will increase in coming years.

Impact of COVID-19 on the Vascular Closure Device Market

The upsurge in COVID-19 infections across the world redirect the resources and professionals towards COVID relief thus, compromising with wound care services, and elective surgeries. The temporary denial is notified for all the non-emergent healthcare services. Enforcing of lockdowns, curfews and fear of getting infected restrict the patients to visit hospitals, clinics or OPDs.

Scope of Report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030

Segments covered

By Type, By Access, By Procedure.

Geographies covered

North America, Europe, APAC, Latin America, and the Middle East & Africa.

Companies Covered: Abbott, Cardinal Health, Medtronic, TZ Medical, Merit Medical Systems, Inc., Rex Medical, Vygon Company, Vasorum Ltd., Terumo Corporation, Cardiva Medical, Inc., Boston Scientific Corporation, Scion BioMedical, Morris Innovative, Inc., Vivasure Medical Ltd., Teleflex Incorporated, Tricol Biomedical, Transluminal Technologies, Meril Life Sciences Pvt. Ltd., Medas USA, Advanced Vascular Dynamics, Marine Polymer Technologies, Inc.

Driver: Rising prevalence of cardiovascular diseases

High occurrence of cardiovascular diseases across the world will render high growth of vascular closure devices market in the forecast period. Rising prevalence of obesity, increasing geriatric population is leading to higher number of patients suffering from cardiovascular diseases.

Challenge: High medical costs and risk associated with vascular closure devices

The high costs of vascular closure devices can hinder the growth of this market. Countries with poor reimbursement policies can pose significant challenge for the adaption of vascular closure devices. The risks associated with the use of vascular closure devices during surgical procedures such as infections, bleeding, device failures and thrombotic events can also restrict the estimated growth.

Opportunity: Rising demand for minimally invasive procedures

The vascular closure devices provide minimal invasion and reduces risk of excessive blood loss during the surgeries. The rising awareness of patients towards minimally invasive procedures will provide growth opportunities for this market. Rising number of hospitals and healthcare funding will also support the growth of vascular closure devices.

Vascular Closure Devices Market by Product type:

Based on product type, the market has been segmented into passive approximators, active approximators and external Hemostatic Devices.

Vascular Closure Devices Market by Access:

Based on access, the market has been segmented into femoral access and radial access.

Vascular Closure Devices Market by Procedures:

Based on procedures, the market has been segmented into interventional cardiology and interventional radiology/vascular surgery.

Vascular Closure Devices Market by Region:

North America accounted for the largest share of Vascular Closure devices market. The large share is ascribed by sophisticated infrastructure, increasing prevalence of cardiovascular diseases and presence of leading players of this market in this region.

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. COVID-19 Impact of the Vascular Closure Device Market
  • 4.4. Market Trends

5. Global Vascular Closure Device Market, By Type, 2021-2030 (USD Million)

  • 5.1. Passive Approximators
    • 5.1.1. Cotton plugs
    • 5.1.2. Sealant or gel-based devices
    • 5.1.3. Compression assists devices
  • 5.2. Active Approximators
    • 5.2.1. Suture-based devices
    • 5.2.2. Clip-based devices
  • 5.3. External Hemostatic Devices

6. Global Vascular Closure Devices Market, By Access, 2021-2030 (USD Million)

  • 6.1. Femoral Access
  • 6.2. Radial Access

7. Global Vascular Closure Devices Market, By Procedures, 2021-2030 (USD Million)

  • 7.1. Interventional Cardiology
  • 7.2. Interventional Radiology/Vascular Surgery

8. Global Vascular Closure Devices Market, By Geography, 2021-2030 (USD Million)

  • 8.1. North America
    • 8.1.1. US
    • 8.1.2. Canada
  • 8.2. Europe
    • 8.2.1. Germany
    • 8.2.2. UK
    • 8.2.3. France
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Rest of Europe
  • 8.3. Asia-Pacific
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. India
    • 8.3.4. Rest of Asia-Pacific
  • 8.4. Rest of the World
    • 8.4.1. Latin America
    • 8.4.2. Middle East & Africa

9. Competitive Landscape

  • 9.1. Introduction
  • 9.2. Market Share Analysis, By Key Players (2021)
  • 9.3. Competitive Scenario
    • 9.3.1. Product Launches
    • 9.3.2. Partnerships, Collaborations and Agreements
    • 9.3.3. Acquisitions
    • 9.3.4. Expansions
    • 9.3.5. Other Developments

10. Company Profiles

  • 10.1. Abbott, Cardinal Health
  • 10.2. Advanced Vascular Dynamics
  • 10.3. Boston Scientific Corporation
  • 10.4. Cardiva Medical, Inc.
  • 10.5. Marine Polymer Technologies, Inc.
  • 10.6. Medas USA
  • 10.7. Medtronic
  • 10.8. Meril Life Sciences Pvt. Ltd.
  • 10.9. Merit Medical Systems, Inc.
  • 10.10. Morris Innovative, Inc.
  • 10.11. Rex Medical
  • 10.12. Scion BioMedical
  • 10.13. Teleflex Incorporated
  • 10.14. Terumo Corporation
  • 10.15. Transluminal Technologies
  • 10.16. Tricol Biomedical
  • 10.17. TZ Medical
  • 10.18. Vasorum Ltd.
  • 10.19. Vivasure Medical Ltd.
  • 10.20. Vygon Company

11. Appendix